Literature DB >> 10438529

Roles of CD4 and coreceptors in binding, endocytosis, and proteolysis of gp120 envelope glycoproteins derived from human immunodeficiency virus type 1.

S L Kozak1, S E Kuhmann, E J Platt, D Kabat.   

Abstract

Infections by human immunodeficiency virus type 1 (HIV-1) involve interactions of the viral envelope glycoprotein gp120 with CD4 and then with a coreceptor. R5 isolates of HIV-1 use CCR5 as a coreceptor, whereas X4 isolates use CXCR4. It is not known whether coreceptors merely trigger fusion of the viral and cellular membranes or whether they also influence the energetics of virus adsorption, the placement of the membrane fusion reaction, and the metabolism of adsorbed gp120. Surprisingly, the pathway for metabolism of adsorbed gp120 has not been investigated thoroughly in any cells. To address these issues, we used purified (125)I-gp120s derived from the R5 isolate BaL and from the X4 isolate IIIB as ligands for binding onto human cells that expressed CD4 alone or CD4 with a coreceptor. The gp120 preparations were active in forming ternary complexes with CD4 and the appropriate coreceptor. Moreover, the cellular quantities of CD4 and coreceptors were sufficient for efficient infections by the corresponding HIV-1 isolates. In these conditions, the kinetics and affinities of (125)I-gp120 adsorptions and their subsequent metabolisms were strongly dependent on CD4 but were not significantly influenced by CCR5 or CXCR4. After binding to CD4, the (125)I-gp120s slowly became resistant to extraction from the cell monolayers by pH 3.0 buffer, suggesting that they were endocytosed with half-times of 1-2 h. Within 20-30 min of endocytosis, the (125)I-gp120s were proteolytically degraded to small products that were shed into the media. The weak base chloroquine strongly inhibited (125)I-gp120 proteolysis and caused its intracellular accumulation, suggesting involvement of a low pH organelle. Results supporting these methods and conclusions were obtained by confocal immunofluorescence microscopy. We conclude that the energetics, kinetics, and pathways of (125)I-gp120 binding, endocytosis, and proteolysis are determined principally by CD4 rather than by coreceptors in cells that contain sufficient coreceptors for efficient infections. Therefore, the role of coreceptors in HIV-1 infections probably does not include steerage or subcellular localization of adsorbed virus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438529     DOI: 10.1074/jbc.274.33.23499

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Platelet-derived growth factor protects neurons against gp120-mediated toxicity.

Authors:  Fuwang Peng; Navneet Dhillon; Shannon Callen; Honghong Yao; Sirosh Bokhari; Xuhui Zhu; Hicham H Baydoun; Shilpa Buch
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

2.  Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.

Authors:  Bryan P Irish; Zafar K Khan; Pooja Jain; Michael R Nonnemacher; Vanessa Pirrone; Saifur Rahman; Nirmala Rajagopalan; Joyce B Suchitra; Kate Mostoller; Brian Wigdahl
Journal:  Am J Infect Dis       Date:  2009-07-01

3.  CCR5/CD4/CXCR4 oligomerization prevents HIV-1 gp120IIIB binding to the cell surface.

Authors:  Laura Martínez-Muñoz; Rubén Barroso; Sunniva Y Dyrhaug; Gemma Navarro; Pilar Lucas; Silvia F Soriano; Beatriz Vega; Coloma Costas; M Ángeles Muñoz-Fernández; César Santiago; José Miguel Rodríguez Frade; Rafael Franco; Mario Mellado
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

4.  Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus.

Authors:  Susan L Kozak; Jean Michel Heard; David Kabat
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1.

Authors:  S E Kuhmann; E J Platt; S L Kozak; D Kabat
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.

Authors:  C M Finnegan; W Berg; G K Lewis; A L DeVico
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Brain-derived neurotrophic factor inhibits human immunodeficiency virus-1/gp120-mediated cerebellar granule cell death by preventing gp120 internalization.

Authors:  Alessia Bachis; Eugene O Major; Italo Mocchetti
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

8.  Envelope variants from women recently infected with clade A human immunodeficiency virus type 1 confer distinct phenotypes that are discerned by competition and neutralization experiments.

Authors:  Sally L Painter; Roman Biek; David C Holley; Mary Poss
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Alpha4(+)beta7(hi)CD4(+) memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection.

Authors:  M Kader; X Wang; M Piatak; J Lifson; M Roederer; R Veazey; J J Mattapallil
Journal:  Mucosal Immunol       Date:  2009-07-01       Impact factor: 7.313

10.  Distinct mechanisms of agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4.

Authors:  Sundararajan Venkatesan; Jeremy J Rose; Robert Lodge; Philip M Murphy; John F Foley
Journal:  Mol Biol Cell       Date:  2003-05-03       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.